vivo prevalence azidothymidine AZT resistance mutations AIDS patient AZT therapy order vivo prevalence AZT resistance mutations AID patients long-term therapy polymerase chain reaction PCR bp pol gene fragment peripheral blood mononuclear cell DNA patient months start AZT therapy PCR products sample clones sample Seven clones post-AZT sample none pre-AZT sample amino acid substitution Tyr nucleotide changes codon ACC TAC change Larder Kemp Science partial AZT resistance virus isolates colony hybridizations synthetic oligonucleotides mutant wild-type sequences clones pre-AZT sample wild-type probe clones post-AZT sample mutant patient first amino acid substitution clinical status patient 